OpenAI CEO Sam Altman Revealed as Mystery Investor Behind Anti-Aging Startup Retro Biosciences

OpenAI CEO Sam Altman has invested $180 million in a mysterious start-up called Retro Biosciences. The start-up's ambitious mission is to add 10 years to the average human lifespan.